Statistical analyses were conducted with SPSS 22.0.<h4>Results</h4>Following treatment, CS patients exhibited reduced CD3+ and CD4+ T-cell levels along with a decreased CD4+/CD8+ ratio, while CD8+ T-cell proportions were elevated (P&lt; 0.05). This evidence concerns the gene CD8A and Cowden syndrome 1.